InspireMD Historical Income Statement

NSPR Stock

USD 2.69 0.10 3.58%

Historical analysis of InspireMD income statement accounts such as Total Revenue of 4.6 M can show how well InspireMD performed in making a profits. Evaluating InspireMD income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of InspireMD's future profits or losses.

Cash Flow Balance Sheet Income Statement

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining InspireMD latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether InspireMD is a good buy for the upcoming year.

Net Income Gross Profit

Build AI portfolio with InspireMD Stock

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in InspireMD. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

To learn how to invest in InspireMD Stock, please use our How to Invest in InspireMD guide.

About InspireMD Income Statement Analysis

InspireMD Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to InspireMD shareholders. The income statement also shows InspireMD investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

InspireMD Income Statement Chart

At this time, InspireMD's Other Operating Expenses is relatively stable compared to the past year. As of 08/03/2025, Total Operating Expenses is likely to grow to about 36.8 M, while Interest Expense is likely to drop slightly above 23.9 K.

Selling General Administrative Total Revenue Other Operating Expenses Total Operating Expenses

Total Revenue

Total revenue comprises all receipts InspireMD generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of InspireMD. It is also known as InspireMD overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.

Most accounts from InspireMD's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into InspireMD current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in InspireMD. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

To learn how to invest in InspireMD Stock, please use our How to Invest in InspireMD guide.At this time, InspireMD's Other Operating Expenses is relatively stable compared to the past year. As of 08/03/2025, Total Operating Expenses is likely to grow to about 36.8 M, while Interest Expense is likely to drop slightly above 23.9 K.

	2022	2023	2024	2025 (projected)
Other Operating Expenses	23.9M	27.3M	40.5M	42.5M
Total Revenue	5.2M	6.2M	7.0M	4.6M

Other Operating Expenses Total Revenue

InspireMD income statement Correlations

	Depreciation And Amortization	Interest Expense	Selling General Administrative	Total Revenue	Other Operating Expenses	Operating Income	Ebit	Ebitda	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Gross Profit	Research Development	Cost Of Revenue	Selling And Marketing Expenses	Net Income From Continuing Ops	Non Recurring	Non Operating Income Net Other	Tax Provision	Interest Income	Net Interest Income	Reconciled Depreciation
Depreciation And Amortization		0.13	-0.21	-0.01	0.57	-0.64	-0.67	-0.66	0.58	-0.67	-0.02	-0.67	0.22	-0.35	0.54	0.33	0.8	-0.09	-0.28	-0.21	0.4	0.4	0.39	0.6
Interest Expense	0.13		-0.01	0.06	0.0	0.01	0.01	0.01	0.03	-0.39	-0.96	-0.39	0.03	0.39	-0.11	-0.27	0.1	-0.3	0.13	0.11	-0.27	0.22	-0.32	-0.08
Selling General Administrative	-0.21	-0.01		0.73	0.15	-0.17	-0.15	-0.15	0.18	-0.12	-0.02	-0.12	0.3	0.77	0.35	0.38	0.2	-0.8	-0.13	0.45	0.09	0.68	0.02	0.46
Total Revenue	-0.01	0.06	0.73		0.51	-0.47	-0.46	-0.46	0.5	-0.43	0.03	-0.43	0.24	0.77	0.57	0.79	0.31	-0.7	-0.29	0.63	0.54	0.53	0.48	0.66
Other Operating Expenses	0.57	0.0	0.15	0.51		-0.99	-0.99	-0.99	1.0	-0.91	0.23	-0.91	0.35	0.12	0.89	0.61	0.66	-0.57	-0.73	0.34	0.67	0.48	0.67	0.7
Operating Income	-0.64	0.01	-0.17	-0.47	-0.99		1.0	1.0	-0.99	0.92	-0.23	0.92	-0.37	-0.08	-0.9	-0.6	-0.73	0.57	0.69	-0.3	-0.64	-0.52	-0.63	-0.72
Ebit	-0.67	0.01	-0.15	-0.46	-0.99	1.0		1.0	-0.99	0.92	-0.22	0.92	-0.37	-0.05	-0.91	-0.61	-0.75	0.55	0.7	-0.29	-0.65	-0.51	-0.65	-0.72
Ebitda	-0.66	0.01	-0.15	-0.46	-0.99	1.0	1.0		-0.99	0.92	-0.22	0.92	-0.37	-0.06	-0.91	-0.61	-0.75	0.56	0.7	-0.29	-0.65	-0.52	-0.65	-0.72
Total Operating Expenses	0.58	0.03	0.18	0.5	1.0	-0.99	-0.99	-0.99		-0.92	0.2	-0.92	0.36	0.15	0.89	0.58	0.69	-0.6	-0.72	0.34	0.64	0.52	0.64	0.69
Income Before Tax	-0.67	-0.39	-0.12	-0.43	-0.91	0.92	0.92	0.92	-0.92		0.17	1.0	-0.36	-0.19	-0.78	-0.44	-0.73	0.63	0.58	-0.31	-0.48	-0.55	-0.45	-0.61
Total Other Income Expense Net	-0.02	-0.96	-0.02	0.03	0.23	-0.23	-0.22	-0.22	0.2	0.17		0.17	-0.01	-0.36	0.24	0.38	-0.01	0.22	-0.26	-0.07	0.4	-0.13	0.46	0.21
Net Income	-0.67	-0.39	-0.12	-0.43	-0.91	0.92	0.92	0.92	-0.92	1.0	0.17		-0.36	-0.19	-0.79	-0.44	-0.73	0.63	0.58	-0.31	-0.48	-0.55	-0.45	-0.62
Income Tax Expense	0.22	0.03	0.3	0.24	0.35	-0.37	-0.37	-0.37	0.36	-0.36	-0.01	-0.36		0.09	0.4	0.28	0.25	-0.41	-0.22	0.0	0.43	0.33	0.06	0.4
Gross Profit	-0.35	0.39	0.77	0.77	0.12	-0.08	-0.05	-0.06	0.15	-0.19	-0.36	-0.19	0.09		0.15	0.21	0.03	-0.73	0.01	0.59	0.0	0.48	-0.05	0.24
Research Development	0.54	-0.11	0.35	0.57	0.89	-0.9	-0.91	-0.91	0.89	-0.78	0.24	-0.79	0.4	0.15		0.67	0.74	-0.65	-0.79	0.39	0.72	0.53	0.71	0.76
Cost Of Revenue	0.33	-0.27	0.38	0.79	0.61	-0.6	-0.61	-0.61	0.58	-0.44	0.38	-0.44	0.28	0.21	0.67		0.45	-0.35	-0.38	0.39	0.79	0.33	0.74	0.76
Selling And Marketing Expenses	0.8	0.1	0.2	0.31	0.66	-0.73	-0.75	-0.75	0.69	-0.73	-0.01	-0.73	0.25	0.03	0.74	0.45		-0.47	-0.31	0.28	0.39	0.5	0.37	0.61
Net Income From Continuing Ops	-0.09	-0.3	-0.8	-0.7	-0.57	0.57	0.55	0.56	-0.6	0.63	0.22	0.63	-0.41	-0.73	-0.65	-0.35	-0.47		0.44	-0.51	-0.2	-0.78	-0.13	-0.53
Non Recurring	-0.28	0.13	-0.13	-0.29	-0.73	0.69	0.7	0.7	-0.72	0.58	-0.26	0.58	-0.22	0.01	-0.79	-0.38	-0.31	0.44		-0.15	-0.61	-0.3	-0.71	-0.53
Non Operating Income Net Other	-0.21	0.11	0.45	0.63	0.34	-0.3	-0.29	-0.29	0.34	-0.31	-0.07	-0.31	0.0	0.59	0.39	0.39	0.28	-0.51	-0.15		0.19	0.16	0.24	0.09
Tax Provision	0.4	-0.27	0.09	0.54	0.67	-0.64	-0.65	-0.65	0.64	-0.48	0.4	-0.48	0.43	0.0	0.72	0.79	0.39	-0.2	-0.61	0.19		0.19	0.87	0.69
Interest Income	0.4	0.22	0.68	0.53	0.48	-0.52	-0.51	-0.52	0.52	-0.55	-0.13	-0.55	0.33	0.48	0.53	0.33	0.5	-0.78	-0.3	0.16	0.19		0.15	0.71
Net Interest Income	0.39	-0.32	0.02	0.48	0.67	-0.63	-0.65	-0.65	0.64	-0.45	0.46	-0.45	0.06	-0.05	0.71	0.74	0.37	-0.13	-0.71	0.24	0.87	0.15		0.67
Reconciled Depreciation	0.6	-0.08	0.46	0.66	0.7	-0.72	-0.72	-0.72	0.69	-0.61	0.21	-0.62	0.4	0.24	0.76	0.76	0.61	-0.53	-0.53	0.09	0.69	0.71	0.67

Click cells to compare fundamentals

InspireMD Account Relationship Matchups

InspireMD income statement Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Depreciation And Amortization	151K	161K	188K	232K	280K	194.1K
Interest Expense	42K	160K	157K	28K	25.2K	23.9K
Selling General Administrative	6.1M	7.4M	8.4M	11.1M	15.3M	8.6M
Total Revenue	2.5M	4.5M	5.2M	6.2M	7.0M	4.6M
Other Operating Expenses	12.9M	19.2M	23.9M	27.3M	40.5M	42.5M
Operating Income	(10.4M)	(14.7M)	(18.7M)	(21.1M)	(33.5M)	(31.8M)
Ebit	(10.4M)	(14.7M)	(18.7M)	(21.1M)	(33.5M)	(31.8M)
Ebitda	(10.2M)	(14.6M)	(18.5M)	(20.9M)	(33.2M)	(31.6M)
Total Operating Expenses	10.5M	15.5M	19.8M	23.0M	35.0M	36.8M
Income Before Tax	(10.5M)	(14.9M)	(18.5M)	(19.9M)	(31.9M)	(30.3M)
Total Other Income Expense Net	(160K)	(157K)	250K	1.3M	1.6M	1.6M
Net Income	(10.5M)	(14.9M)	(18.5M)	(19.9M)	(32.0M)	(30.4M)
Gross Profit	83K	754K	1.1M	1.8M	1.5M	1.0M
Research Development	2.2M	5.2M	7.8M	8.0M	13.6M	14.3M
Cost Of Revenue	2.4M	3.7M	4.1M	4.4M	5.5M	3.3M
Selling And Marketing Expenses	2.1M	2.9M	3.7M	3.9M	6.1M	3.5M
Net Income From Continuing Ops	(10.5M)	(14.9M)	(18.5M)	(19.9M)	(32.0M)	(30.4M)
Net Income Applicable To Common Shares	(10.0M)	(10.5M)	(14.9M)	(18.5M)	(21.3M)	(22.3M)
Net Interest Income	(160K)	(157K)	250K	1.3M	1.6M	1.6M
Reconciled Depreciation	151K	161K	188K	232K	280K	206.3K

Additional Tools for InspireMD Stock Analysis

When running InspireMD's price analysis, check to measure InspireMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InspireMD is operating at the current time. Most of InspireMD's value examination focuses on studying past and present price action to predict the probability of InspireMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InspireMD's price. Additionally, you may evaluate how the addition of InspireMD to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC

InspireMD Historical Income Statement

About InspireMD Income Statement Analysis

InspireMD Income Statement Chart

Total Revenue

Other Operating Expenses

Total Operating Expenses

InspireMD income statement Correlations

InspireMD Account Relationship Matchups

High Positive Relationship

High Negative Relationship

InspireMD income statement Accounts

Additional Tools for InspireMD Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Operating Expenses	+ 1.0	Other Operating Expenses
Ebit	+ 1.0	Operating Income
Ebitda	+ 1.0	Operating Income
Ebitda	+ 1.0	Ebit
Net Income	+ 1.0	Income Before Tax
Income Before Tax	+ 0.92	Operating Income

Total Operating Expenses	- 0.99	Ebitda
Total Operating Expenses	- 0.99	Ebit
Total Operating Expenses	- 0.99	Operating Income
Ebitda	- 0.99	Other Operating Expenses
Ebit	- 0.99	Other Operating Expenses
Operating Income	- 0.99	Other Operating Expenses